A GLP-1 blocker acts by inhibiting the GLP-1 receptor, which modulates the downstream inflammatory pathways linked to: cytokine production immune system activation oxidative stress inflammatory signaling in tissues such as the liver, fat cells, and gut In low doses, blocking GLP-1 receptors appears to influence the immune system without significantly interfering with glucose control which is why this approach is being studied specifically for inflammation rather than metabolic disease
This makes injections highly effective for pernicious anaemia and other malabsorption syndromes, including post-gastrectomy states, Crohn's disease affecting the terminal ileum, and certain medications that interfere with B12 uptake
Lipo B12 injections work differently than oral B12 supplements
Research suggests 5-Amino-1MQ may support metabolic health, cellular energy production, NAD+ optimization, and body composition when combined with proper nutrition and exercise
Furthermore, owing to different reasons, a considerable number of cancer patients did not respond to these therapeutics efficiently (8,9)
